Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
The New England Journal of Medicine
|
December 28, 2022
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19
Zhujun Cao, Weiyi Gao, Hong Bao, et al.
BMJ (Clinical Research Ed.)
|
May 16, 2020
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang, Zhujun Cao, Mingfeng Han, et al.
Medcomm
|
November 4, 2024
Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study
Shanghao Liu, Jia Li, Yujun Wong, et al.
The American Journal of Gastroenterology
|
August 16, 2022
A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study
Chuan Liu, Zhujun Cao, Huadong Yan, et al.
The American Journal of Gastroenterology
|
July 19, 2023
Correction to: A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study
Chuan Liu, Zhujun Cao, Huadong Yan, et al.
JAMA Network Open
|
March 13, 2024
COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment: A Randomized Clinical Trial
Zhitao Yang, Yu Xu, Ruizhi Zheng, et al.
Clinical and Molecular Hepatology
|
July 11, 2024
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
Chuan Liu, Hong You, Qing-Lei Zeng, et al.
BMJ Open
|
July 11, 2024
Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China
Chuan Liu, Liting Zhang, Shuairan Zhang, et al.
Gastroenterology
|
July 25, 2025
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External Validation
Scott Silvey, Patrick S Kamath, Jacob George, et al.
Gut
|
June 5, 2026
Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective
Florence Wong, Danielle Adebayo, Jacob George, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
The New England Journal of Medicine
|
December 28, 2022
VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19
Zhujun Cao, Weiyi Gao, Hong Bao, et al.
BMJ (Clinical Research Ed.)
|
May 16, 2020
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang, Zhujun Cao, Mingfeng Han, et al.
Medcomm
|
November 4, 2024
Prognostic impact of age on outcomes of hepatic decompensation in patients with compensated cirrhosis (CHESS2102): an international, multicenter cohort study
Shanghao Liu, Jia Li, Yujun Wong, et al.
The American Journal of Gastroenterology
|
August 16, 2022
A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study
Chuan Liu, Zhujun Cao, Huadong Yan, et al.
The American Journal of Gastroenterology
|
July 19, 2023
Correction to: A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study
Chuan Liu, Zhujun Cao, Huadong Yan, et al.
JAMA Network Open
|
March 13, 2024
COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment: A Randomized Clinical Trial
Zhitao Yang, Yu Xu, Ruizhi Zheng, et al.
Clinical and Molecular Hepatology
|
July 11, 2024
Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
Chuan Liu, Hong You, Qing-Lei Zeng, et al.
BMJ Open
|
July 11, 2024
Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China
Chuan Liu, Liting Zhang, Shuairan Zhang, et al.
Gastroenterology
|
July 25, 2025
Enhancement of Inpatient Mortality Prognostication With Machine Learning in a Prospective Global Cohort of Patients With Cirrhosis With External Validation
Scott Silvey, Patrick S Kamath, Jacob George, et al.
Gut
|
June 5, 2026
Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective
Florence Wong, Danielle Adebayo, Jacob George, et al.
Page
of 7